Karijn P.M. Suijkerbuijk
Utrecht University(NL)Heidelberg University(DE)University Hospital Heidelberg(DE)University Medical Center Utrecht(NL)University Medical Center Utrecht(NL)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, CAR-T cell therapy research, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses
Most-Cited Works
- → Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma(2022)495 cited
- → Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial(2022)332 cited
- → Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis(2017)297 cited
- → Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis(2017)259 cited
- → ESMO Guidance for Reporting Oncology real-World evidence (GROW)(2023)189 cited
- → Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1–Treated Patients in the Dutch Melanoma Treatment Registry(2020)177 cited